SUMMARY -Although the in vitro fertilization-intra-cytoplasmic sperm injection (IVF-ICSI) has been utilized widely, the management in patients with an autoimmune disease is still a challenge. Th e aim of this study was to demonstrate IVF-ICSI outcomes in infertile women with familial Mediterranean fever (FMF). Patient data were collected from the cases registered from January 2006 until January 2014. A total of 6152 assisted reproductive technology (ART) cycles were analyzed retrospectively in the Ankara Zekai Tahir Burak Women's Health Education and Research Hospital. Ten infertile women with FMF were included in the study. Baseline clinical and laboratory characteristics were collected and perinatal outcomes evaluated. Th e mean age (years), duration of infertility (years) and body mass index (kg/m 2 ) were 29.9±5.3, 5.7±5.3 and 27.9±5.7, respectively. Th e mean baseline follicle-stimulating hormone (FSH; IU/L), estradiol (E2; pg/mL) and antral follicle count were 7.0±2.4, 48.1±15.8 and 7.9±2.9, respectively. Th e distribution of ovarian response was heterogeneous. Fourteen cycles in ten patients were evaluated. Embryo transfer could be achieved in only ten cycles. Th ree out of ten patients became pregnant. No adverse perinatal outcome was observed. Our fi ndings indicate that FMF might have no impact on ART cycles.
Introduction
Although the in vitro fertilization-intra-cytoplasmic sperm injection (IVF-ICSI) has been utilized widely, the management in patients with an autoimmune disease is still a challenge. Numerous mechanisms could lead to infertility such as premature ovarian failure, harmful eff ects of antibodies on implantation and fertilization, autoimmune oophoritis, etc. Also, antibodies may lead to placental damage, immune rejection, and recurrent pregnancy failure 1, 2 . Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by recurrent fever attacks and abdominal pain. It aff ects mainly Jewish, Armenian, and Turkish people. In these populations, the incidence of the disease has been documented as being 1/500-1/1000 3 . In accordance with the incidence of FMF in Turkish population, the 10 women cohort was accepted as normal. FMF occurs due to a mutation in the Mediterranean fever (MEFV) gene. Th e pyrin protein which is expressed by MEFV gene leads to a decrease in the infl ammatory mediator levels. Th erefore, an abnormality of the gene can lead to an increase in infl ammatory response [4] [5] [6] [7] . Th e IVF-ICSI has been utilized all over the world for more than three decades now. However, the management of IVF-ICSI in FMF patients remains a challenge for clinicians. Although there are many published studies about the infl uence of FMF on infertility, the association between FMF and IVF-ICSI out-come is still controversial 7 . Th e relationship between infertility and FMF was fi rst introduced by Ismajovitch et al. 8 . Th ey claimed that FMF could cause infertility due to ovulatory dysfunction in up to 87% of cases. Dor et al. report that oligomenorrhea was more common in FMF group than in the general population (46% vs. 31%) 9 . Unfortunately, the reason for oligomenorrhea is not known. In the same study, interestingly, the pelvic adhesion rate was found to be similar in FMF and control groups, i.e. 31% and 28%, respectively 9 . Yasar et al. report on retrospective evaluation of 46 pregnant women with FMF, claiming that FMF increased the premature rupture of membranes (PROM), recurrent miscarriages, and preterm delivery rates 10 . Th e mechanisms of infertility and impact on perinatal outcome due to FMF remains unclear 11 . Th erefore, we aimed to assess whether there is infl uence of FMF on IVF outcome.
Material and Methods

Study design
Th e aim of this retrospective cohort study was to analyze our assisted reproductive technology (ART) cycle results in FMF patients. Th e study protocol was approved and ethical consent granted by the local Ethics Committee. Patient data were collected from the cases registered from January 2006 until January 2014. A total of 6152 women admitted to our IVF unit were evaluated. Ten infertile FMF women having undergone 14 ART cycles were included in the study.
Th e diagnosis of FMF was made by an internal specialist according to clinical symptoms such as intermittent fever, recurrent abdominal pain, family history, and the complaints subsiding with colchicine treatment. All study women were receiving colchicine. Colchicine (Colchicum dispert®, 0.5 mg tbl, Recordati, Turkey) was administered at a dose of 0.5 mg b.i.d. to suppress FMF attacks.
Gonadotropin stimulation for ART, oocyte retrieval and sample collection
Agonist and antagonist protocols were used for controlled ovarian hyperstimulation (COH) individually. Flexible daily gonadotropin releasing hormone (GnRH) antagonist protocol was preferred to induce pituitary down-regulation (Cetrotide 0.25 mcg, Serono, Switzerland). A dose of 150-225 U daily rec-FSH (Gonal-F, Serono, Istanbul) and/or human menopausal gonadotropin (HMG) (Menogon, Ferring, Switzerland) were started on day 3 of the cycle and continued for the fi rst 3 days of stimulation, after which daily dosing was determined individually. Th e GnRH antagonist was started when the leading follicle reached a diameter of 12-14 mm. Serial estradiol (E2) levels and two-dimensional follicle measurements by transvaginal ultrasound imaging (LOGIC 200 PRO, General Electric, Korea) were performed until at least two dominant follicles reached 18 mm or greater in diameter. Human chorionic gonadotropin (Pregnyl, 10,000 U, im, Organon, Th e Netherlands) was administered, followed by transvaginal oocyte retrieval 36 h later. ICSI was performed in all patients according to our clinical practice. Luteal phase support was routinely administered as progesterone in the form of Crinone 8% gel (Serono, Istanbul), 90 mg daily for 14 days, when a pregnancy test was performed. Clinical pregnancy was diagnosed by ultrasound demonstration of heartbeat in the intrauterine gestational sac. Ongoing pregnancies were followed at our perinatology department. Data on perinatal outcomes were obtained from hospital records.
Statistical analysis
Statistical analysis was performed using the SPSS 15.00 (SPSS Inc., Chicago, IL, USA). Descriptive analysis was performed.
Results
Ten patients were included in the study. One and two cycles were performed in 6 and 4 women, respectively. Th e mean age (years), duration of infertility (years) and body mass index (kg/m 2 ) were 29.9±5.3, 5.7±5.3 and 27.9±5.7, respectively. Th e mean baseline follicle stimulating hormone (FSH; IU/L), E2 (pg/ mL) and antral follicle count were 7.0±2.4, 48.1±15.8 and 7.9±2.9, respectively. Demographic and clinical characteristics of study patients are shown in Table 1 .
Age, baseline FSH and E2 levels, total gonadotropin dose, peak E2 level, endometrial thickness, retrieved oocytes, metaphase II (M II) oocytes, 2 pronucleus (2 PN), transferred embryo number, and clini-cal pregnancy rate for each patient are shown in Table  2 . Th e causes of infertility were male factor in 4 (40%), unexplained in 3 (30%), poor ovarian reserve in 2 (20%) cases, and tubal factor in 1 (10%) case. Th e distribution of ovarian response was heterogeneous. Endometrial thickness was found to be within the normal range. Fertilization failure occurred in two patients without male factor. Embryo transfer could be achieved in only ten cycles. Preimplantation genetic diagnosis was not performed because of the patients' choice.
Clinical pregnancy occurred in three women. All these pregnancies were followed at perinatology department. Th ere were no problems throughout pregnancy and newborns were healthy. Th e mode of delivery was cesarean section in all three women. Th e birth weight of the babies was 3020 g, 2400 g and 3550 g.
Discussion
In this study, records of ten infertile women with FMF admitted to the IVF unit of Ankara Zekai Tahir Burak Women's Health Education and Research Hospital were reviewed retrospectively. Th ree of ten patients became pregnant. As mentioned above, a total of 6152 women were admitted to our IVF unit and 10 FMF cases were detected. Th ese ratios were consistent with the literature.
Familial Mediterranean fever is a chronic disease and the relationship between FMF and infertility is not clear. Various mechanisms could contribute to infertility in patients with FMF. Oligomenorrhea and pelvic adhesions (due to recurrent peritoneal infl ammation) are the main causes of infertility in FMF 8, 9 . Colchicine has been utilized for the treatment of FMF since 1974. Colchicine reduces infertility rates as a re- 13 investigated fertility and obstetric history of 36 women with FMF. All the patients were also receiving colchicine treatment. Th irteen (36%) women had infertility. Th e causes of infertility were ovulatory dysfunction in 6 (46%), peritoneal adhesion in 4 (31%) and unexplained in 3 (23%) cases. However, the limitation of that study was absence of serum hormone levels such as FSH, luteinizing hormone and E2 13 . In our study, serum hormone levels were determined and three patients had oligomenorrhea. Th ere are confl icting data about FMF and its infl uence on infertility. Mamou et al. 14 report that FMF could lead to ovarian insuffi ciency. In the present study, poor ovarian response was observed in three patients. On the contrary, Zayed et al. 15 found that the causes of infertility in FMF were the same as in the general population.
In the light of these data, there is still debate on this issue. Unfortunately, the drawbacks of these studies were small sample sizes and heterogeneity of the populations.
In conclusion, our results indicated that baseline clinical and laboratory characteristics were variable as in the general infertile population. FMF could cause infertility via diff erent mechanisms. In the present study, although the spectrum of the ovarian reserves was variable, we detected similar live birth rates as previously reported. Our study showed that FMF might have no negative impact on ART cycles.
